1-7 of 7
Anke Maes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Oxidative Phosphorylation and Glycolysis Reduces Viability in Multiple Myeloma By Affecting mTOR-Mediated Protein Synthesis

Inge Oudaert, Arne Van der Vreken, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Elke De Bruyne, Kim De Veirman, Ann Massie, Karin Vanderkerken, Eline Menu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7078–7079.
https://doi.org/10.1182/blood-2022-167025
Published: 2022
Journal Articles

Pyrroline-5-Carboxylate Reductase 1: A Novel Target for Sensitizing Myeloma to Cytotoxic Agents By Inhibition of PRAS40-Mediated Protein Synthesis

Inge Oudaert, Hatice Satilmis, Philip Vlummens, Anke Maes, Elke De Bruyne, Karin Vanderkerken, Sarah-Maria Fendt, Kim De Veirman, Eline Menu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1574.
https://doi.org/10.1182/blood-2021-149156
Published: 2021
Journal Articles

Histone Methyltransferases G9a and GLP; Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Treatment

Eva De Smedt, Julie Devin, Hui Liu, Anke Maes, Ken Maes, Kim De Veirman, Eline Menu, PhD, Karin Vanderkerken, PhD, Jerome Moreaux, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4356.
https://doi.org/10.1182/blood.V130.Suppl_1.4356.4356
Published: 2017
Journal Articles

The Anaphase Promoting Complex/Cyclosome: A New Promising Target in Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma

Anke Maes, Eva De Smedt, Kim De Veirman, Ken Maes, Eline Menu, PhD, Els Van Valckenborgh, PhD, Karin Vanderkerken, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2757.
https://doi.org/10.1182/blood.V130.Suppl_1.2757.2757
Published: 2017
Journal Articles

Kinome Expression Profiling in Multiple Myeloma Identifies New Therapeutic Targets

Hugues de Boussac, PhD, Angelique Bruyer, Nicolas Robert, Anke Maes, Laure Vincent, Anja Seckinger, Guillaume Cartron, Dirk Hose, MD, Elke De Bruyne, PhD, Alboukadel Kassambara, PhD, Jerome Moreaux, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1766.
https://doi.org/10.1182/blood.V130.Suppl_1.1766.1766
Published: 2017
Journal Articles

RAS Association Domain Family Member 4 (RASSF4): A New Potent Tumor Suppressor in Multiple Myeloma

Eva De Smedt, Ken Maes, PhD, Stefan Verhulst, Hui Lui, Alboukadel Kassambara, PhD, Anke Maes, Dirk Hose, MD, Karine Breckpot, Jerome Moreaux, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2016) 128 (22): 2057.
https://doi.org/10.1182/blood.V128.22.2057.2057
Published: 2016
Journal Articles

Targeting the Anaphase Promoting Complex/Cyclosome (APC/C) in Multiple Myeloma

Susanne Lub, Anke Maes, Ken Maes, Kim De Veirman, Xavier Leleu, MD PhD, Eline Menu, PhD, Elke De Bruyne, PhD, Karin Vanderkerken, PhD, Els Van Valckenborgh, PhD
Journal: Blood
Blood (2014) 124 (21): 2097.
https://doi.org/10.1182/blood.V124.21.2097.2097
Published: 2014